Market Overview –

By the end of the projection year, the global radiotherapy market will be worth $9641.89 million (a CAGR of 5.49%).

Radiotherapy, or radiation therapy, is frequently use to treat cancer. Two distinct dosages exist. Similar to dental x-rays, low-dose radiation therapy allows doctors to see inside the body. On the other hand, high-dose radiation therapy is effective in reducing the size of the tumour and killing any cancer cells it may have reaches.

Rising cancer rates, an ageing population, widespread acceptance of radiation therapy as a viable treatment option, and publicity touting its benefits have all contribute to a surge in recent years in the number of people seeking radiation treatment. Improvements in radiation therapy machinery enable by technological progress.

The previous decade has seen significant technological advancements that have result in more accessible, affordable, and efficient cancer treatments. The development of real-time imaging has reduce the needless destruction of healthy tissue, enhance the ability to monitor and manage tumor’s, and stimulate economic development in many countries. The global market for radiation therapy is being propeller by rising standards of living and consumer spending.

COVID 19 Analysis –

Radiotherapy is only one area of medicine that has seen a significant drop in demand as a result of the global COVID 19 epidemic. A global pandemic has results in a 20% increase in the number of cancer patients due to the postponement of various surgeries as the government prioritises providing aid to those with chronic obstructive pulmonary disease (COPD). The PPE (personal protection equipment) kit’s declining market share can be attribute in part to new regulations requiring its reduce use.

Market Dynamics –

The success of radiotherapy treatments has prompter the creation of a number of events, including conferences and symposia, in recent years. At such occasions, there is a heightener focus on educating the public about the many benefits of radiotherapy as a treatment option for cancer. As an example, Portugal is set to host the 6th World Congress on Cancer in September 2022. The 6th Cancer World Congress 2022 will focus on personalize cancer diagnosis and therapy, whereas the 5th Global Cancer Summit – 2022 (GCS-2022) was hostel virtually in May 2022 by BioGenesis Health Cluster, Bangalore and Global Cancer Foundation.

Market Scope and Market Size –

The global market for radiotherapy can be broken down into a number of submarkets base on the different types of radiotherapy offer. Due to its widespread use in the treatment of cancers such as breast, lung, prostate, colorectal, lymphoma, liver, thyroid, brain, cervical, and spinal, the external-beam radiation therapy segment is project to lead the market in 2022.

Read more articles – Global Body Fat Reduction Market , By Type , By Applications…

The rising demand for external-beam radiation therapy devices like LINACs, proton therapy, cybercides, and gamma knives to treat cancers like breast, lung, prostate, colorectal, lymphoma, liver, thyroid, brain, cervical, and spinal will propel the external beam radiotherapy segment to the forefront of the market by 2022. The global population is ageing, which will increase the need for external beam radiotherapy to treat cancer.

Customization Available –

Zion Market Research is at the forefront of cutting-edge exploratory studies. We are happy to provide our current and future clients with data and analysis that is tailore to their specific needs. Clinical trial results data, a literature review, a recondition market analysis, and a product base analysis are just some of the optional extras that can be add to the study upon request. Technology-base analysis as well as market portfolio techniques are both useful in doing market research into potential rivals.

Competitive Landscape –

A company’s presence in the radiotherapy market is describe in detail in this section. An overview of the company, its finances, revenue, market potential, R&D investment, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trial pipelines, product approvals, patents, product breadth and depth, application dominance, and a technology lifeline curve are all include. All of the aforementioned information is strictly relevant to the company’s research into the worldwide radiotherapy market.

Key Companies profiled in this report include –

Siemens Healthineers
GE Healthcare
Ion Beam Applications
Elekta
Mirada Medical
Isoray Inc.
Varian Medical Systems Inc.
Accuray Incorporated
Becton, Dickinson and Company
Mevion Medical Systems
Eckert & Ziegler

By Type –

External Beam Radiation Therapy
Systemic Radiation therapy
Internal Beam Radiation Therapy

By Applications –

Skin and Lip Cancer
Breast Cancer
Spine Cancer
Prostate Cancer
Lung Cancer
Cervical Cancer
Head & Neck Cancer

By Regions –

North America
Europe
Asia-Pacific
LAMEA

LEAVE A REPLY

Please enter your comment!
Please enter your name here